Status:
COMPLETED
WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.
Lead Sponsor:
Hoffmann-La Roche
Collaborating Sponsors:
Trimeris
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the tolerability of a subcutaneous needle-free injection device used to administer Fuzeon, compared with the standard needle/syringe supplied with commercial F...
Eligibility Criteria
Inclusion
- male or female patients, \>=18 years of age with HIV-1 infection;
- previously treated with antiretroviral agents.
Exclusion
- prior use of Fuzeon or T-1249;
- inability to self-inject;
- active, untreated opportunistic infection.
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00233883
Start Date
August 1 2005
End Date
July 1 2006
Last Update
November 3 2015
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Long Beach, California, United States, 90813
2
Los Angeles, California, United States, 90022
3
Los Angeles, California, United States, 90036
4
Los Angeles, California, United States, 90210